A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
漢方方剤冠元顆粒が糖尿病性腎障害への進展を改善―LLC-PK1細胞とdb/dbマウスを用いた検討―
Chinese prescription Kangen-karyu ameliorates the development of diabetic renal damage using LLC-PK1 cells and db/db mice
2018
The Japanese Journal of Nephrology and Pharmacotherapy
Chinese prescription Kangen-karyu ameliorates the development of diabetic renal damage using LLC-PK1 cells and db/db mice
Traditional Chinese medicine has received much attention as a source of novel therapeutic agents due to multiple bene cial effects and the absence of toxic and/or side effects. Traditional Chinese medicine in uences changes at multi-system and multi-organ levels. The present study reports the therapeutic evidence for Kangen-karyu, one of our major compounds of interest among traditional Chinese medicine agents, from experimental models related to diabetic kidney. Firstly, we investigated the
doi:10.24595/jjnp.7.3_171
fatcat:n7kypkoklfetrima3uohoevngu